| human | Q5 |
| P496 | ORCID iD | 0000-0002-0282-6469 |
| P734 | family name | Seidlein | Q57705744 |
| Seidlein | Q57705744 | ||
| Seidlein | Q57705744 | ||
| P735 | given name | Lorenz | Q15635254 |
| Lorenz | Q15635254 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P21 | sex or gender | male | Q6581097 |
| Q91244673 | "Nine Dimensions": A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, Myanmar |
| Q53703441 | A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multi Drug Resistant Falciparum Malaria in Cambodian Villages. |
| Q39972060 | A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan |
| Q46908354 | A cost function analysis of shigellosis in Thailand |
| Q33408812 | A look back at an ongoing problem: Shigella dysenteriae type 1 epidemics in refugee settings in Central Africa (1993-1995) |
| Q46248702 | A multi-level spatial analysis of clinical malaria and subclinical Plasmodium infections in Pailin Province, Cambodia |
| Q28767862 | A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology |
| Q21144301 | A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India |
| Q33330938 | A study of typhoid fever in five Asian countries: disease burden and implications for controls |
| Q39697234 | Acceptability and accessibility of a Shigellosis vaccine in Nha Trang city of Viet Nam. |
| Q33327527 | Adults' perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children |
| Q56432853 | Affordable house designs to improve health in rural Africa: a field study from northeastern Tanzania |
| Q36232144 | Airflow attenuation and bed net utilization: observations from Africa and Asia |
| Q36041729 | Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine |
| Q47919304 | Antimalarial use during pregnancy and its effect on birthweight |
| Q33301096 | Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones |
| Q21032505 | Artemisinin resistance: current status and scenarios for containment |
| Q24630683 | Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial |
| Q36580228 | Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial |
| Q33910444 | Assessment and comparative analysis of a rapid diagnostic test (Tubex®) for the diagnosis of typhoid fever among hospitalized children in rural Tanzania |
| Q34968407 | Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria |
| Q28596625 | Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting |
| Q57181242 | Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi |
| Q28602102 | Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos) |
| Q39029573 | Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? |
| Q36337171 | Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group |
| Q39354871 | Challenges to replace ACT as first-line drug |
| Q30373379 | Characteristics of a pandemic clone of O3 : K6 and O4 : K68 Vibrio parahaemolyticus isolated in Beira, Mozambique. |
| Q38063986 | Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria |
| Q41919917 | Cholera outbreak in Yemen |
| Q48066726 | Classical RS1 and environmental RS1 elements in Vibrio cholerae O1 El Tor strains harbouring a tandem repeat of CTX prophage: revisiting Mozambique in 2005. |
| Q35031846 | Climate variability and the outbreaks of cholera in Zanzibar, East Africa: a time series analysis |
| Q34532346 | Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions |
| Q30332251 | Clinical, epidemiological, and socioeconomic analysis of an outbreak of Vibrio parahaemolyticus in Khanh Hoa Province, Vietnam. |
| Q91883525 | Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers |
| Q28074520 | Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review |
| Q37642966 | Community engagement and the social context of targeted malaria treatment: a qualitative study in Kayin (Karen) State, Myanmar |
| Q40051932 | Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar |
| Q64056682 | Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region |
| Q47553056 | Community participation during two mass anti-malarial administrations in Cambodia: lessons from a joint workshop |
| Q37564052 | Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey |
| Q34277317 | Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review |
| Q36551751 | Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines |
| Q33693625 | Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial |
| Q55438871 | Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia. |
| Q34718583 | Comparison of rapid diagnostic tests for the detection of Plasmodium vivax malaria in South Korea |
| Q33302557 | Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India |
| Q58897741 | Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan |
| Q57105484 | Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011 |
| Q92819552 | Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR |
| Q55461941 | Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children. |
| Q45925153 | Correction: The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. |
| Q35079657 | Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa |
| Q28742561 | Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010 |
| Q36495596 | Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration |
| Q28482447 | Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement |
| Q36249062 | Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique |
| Q31119501 | Diarrhoea episodes and treatment-seeking behaviour in a slum area of North Jakarta, Indonesia. |
| Q40498833 | Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China |
| Q35016669 | Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children |
| Q40061329 | Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study |
| Q39708620 | Effectiveness of mass oral cholera vaccination in Beira, Mozambique |
| Q35925829 | Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial |
| Q24658073 | Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age |
| Q47987562 | Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa |
| Q37061435 | Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial |
| Q35044847 | Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study |
| Q37061211 | Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study |
| Q34762426 | Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children |
| Q33932114 | Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities |
| Q34290950 | Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies |
| Q31057455 | Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India |
| Q30984758 | Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hdospital in Tanzania and a comparison with previous studies |
| Q42644116 | Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR. |
| Q38460606 | Factors associated with reported diarrhoea episodes and treatment-seeking in an urban slum of Kolkata, India |
| Q39736985 | Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique |
| Q25256629 | Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population |
| Q38399949 | Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance |
| Q39868883 | Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan |
| Q57937173 | Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique |
| Q51693261 | Geographic analysis of shigellosis in Vietnam. |
| Q41364702 | Global extent of chloroquine-resistant Plasmodium vivax - Authors' reply |
| Q34259032 | Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis |
| Q44502813 | Healthcare use for diarrhoea and dysentery in actual and hypothetical cases, Nha Trang, Viet Nam. |
| Q44716334 | Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis |
| Q57271823 | Herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations and the implications for malaria elimination |
| Q36836571 | History of malaria treatment as a predictor of subsequent subclinical parasitaemia: a cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia |
| Q38975837 | How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria |
| Q47410855 | Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis |
| Q52872251 | Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study. |
| Q30978129 | Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies |
| Q44758797 | Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique |
| Q33263723 | Isolation of Salmonella enterica subspecies enterica serovar Paratyphi B dT+, or Salmonella Java, from Indonesia and alteration of the d-tartrate fermentation phenotype by disrupting the ORF STM 3356. |
| Q90628914 | Knowledge gaps in the construction of rural healthy homes: A research agenda for improved low-cost housing in hot-humid Africa |
| Q34804222 | Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]. |
| Q33842153 | Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey |
| Q36204289 | Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border |
| Q58897746 | Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam |
| Q36062989 | Malaria Epidemiology in Kilifi, Kenya during the 21st Century: What Next? |
| Q35712522 | Malaria eradication and elimination: views on how to translate a vision into reality |
| Q39345614 | Malaria vaccines: past, present and future |
| Q34266346 | Mass administrations of antimalarial drugs |
| Q33709109 | Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage |
| Q89547772 | Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials |
| Q31016687 | Mass psychogenic illness following oral cholera immunization in Ca Mau City, Vietnam |
| Q40053271 | Methods for the field evaluation of quantitative G6PD diagnostics: a review |
| Q50085131 | Model citizen |
| Q40518745 | Multidisciplinary studies of disease burden in the Diseases of the Most Impoverished Programme. |
| Q30352675 | Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage. |
| Q37119279 | Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries |
| Q91928193 | Novel Approaches to Control Malaria in Forested Areas of Southeast Asia |
| Q28595148 | Novel Vector Control Approaches: The Future for Prevention of Zika Virus Transmission? |
| Q36705880 | Numerical Distributions of Parasite Densities During Asymptomatic Malaria |
| Q34121098 | Oral cholera vaccine development and use in Vietnam |
| Q45923795 | Oral quinine for the treatment of uncomplicated malaria. |
| Q31035751 | Organizational aspects and implementation of data systems in large-scale epidemiological studies in less developed countries |
| Q30350881 | Pandemic serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus associated with diarrhea in Mozambique: spread of the pandemic into the African continent. |
| Q30235396 | Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming |
| Q39941003 | Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania |
| Q91959120 | Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis |
| Q36725244 | Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies |
| Q53588316 | Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. |
| Q37082655 | Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity |
| Q35072841 | Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia |
| Q35760893 | Plasmodium vivax treatments: what are we looking for? |
| Q36558387 | Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria |
| Q45348753 | Potential cost-effectiveness of a rotavirus immunization program in rural China |
| Q43943738 | Pre-referral rectal artesunate in severe malaria |
| Q35845345 | Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial |
| Q55016452 | Preventing cholera outbreaks through early targeted interventions. |
| Q27027939 | Primaquine radical cure of Plasmodium vivax: a critical review of the literature |
| Q46974317 | Private demand for cholera vaccines in Beira, Mozambique |
| Q43112618 | Progress in Medicine: Experts Take Stock |
| Q112301311 | Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis |
| Q40404190 | Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh |
| Q27006552 | Rationale for short course primaquine in Africa to interrupt malaria transmission |
| Q59097874 | Reducing stunting among children: the potential contribution of diagnostics |
| Q34165617 | Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar |
| Q42557275 | Response to "Poor control vaccines in two randomised trials of malaria vaccine?". |
| Q40435123 | Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings |
| Q27024922 | Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report |
| Q39769526 | Risk factors for shigellosis in Thailand |
| Q47108422 | Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar |
| Q54268700 | Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. |
| Q28744573 | Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children |
| Q34359766 | Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy |
| Q33228201 | Salmonella paratyphi A rates, Asia |
| Q36346372 | Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria |
| Q28743081 | Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites |
| Q92055897 | Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial |
| Q37615926 | Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia |
| Q40346092 | Surveillance of shigellosis by real-time PCR suggests underestimation of shigellosis prevalence by culture-based methods in a population of rural China |
| Q57099925 | The Epidemiology of Cholera in Zanzibar: Implications for the Zanzibar Comprehensive Cholera Elimination Plan |
| Q35986983 | The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan |
| Q37291543 | The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border |
| Q24812819 | The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance |
| Q34169960 | The burden of invasive bacterial infections in Pemba, Zanzibar |
| Q34482008 | The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial |
| Q21144515 | The case for reactive mass oral cholera vaccinations |
| Q54239493 | The case for ring vaccinations with special consideration of oral cholera vaccines. |
| Q30666192 | The challenges of introducing routine G6PD testing into radical cure: a workshop report |
| Q58614508 | The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos |
| Q34272998 | The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia |
| Q36111884 | The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam |
| Q52808429 | The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial. |
| Q37525005 | The failure of screening and treating as a malaria elimination strategy |
| Q56379688 | The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study |
| Q21144553 | The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa |
| Q64246709 | The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial |
| Q31031672 | The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study |
| Q44224799 | The need for another typhoid fever vaccine |
| Q49342038 | The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study |
| Q47111312 | The prevalence, incidence and prevention of Plasmodium falciparum infections in forest rangers in Bu Gia Map National Park, Binh Phuoc province, Vietnam: a pilot study |
| Q92331819 | The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos |
| Q30202347 | The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans |
| Q37060884 | The use of a computerized database to monitor vaccine safety in Viet Nam. |
| Q40444791 | The use of typhoid vaccines in Asia: the DOMI experience |
| Q92405055 | The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR |
| Q30777651 | The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations |
| Q38150312 | The value of and challenges for cholera vaccines in Africa |
| Q37227549 | Therapy of uncomplicated malaria in children: a review of treatment principles, essential drugs and current recommendations |
| Q47594749 | Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design |
| Q36937696 | Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. |
| Q24647991 | Trend and disease burden of bacillary dysentery in China (1991-2000) |
| Q34092738 | Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004 |
| Q33903560 | Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades |
| Q34092762 | Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India. |
| Q36522998 | Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever |
| Q36152700 | Vaccines for cholera control: does herd immunity play a role |
| Q36952579 | Vivax malaria and bacteraemia: a prospective study in Kolkata, India |
| Q36017165 | Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan |
| Q47562772 | Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). |
| Q33222697 | Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia |
| Q57032930 | “Nine Dimensions”: A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, Myanmar |
Search more.